Daisy Robinton Ph.D.
Co-Founder and CEO
Dr. Daisy Robinton is passionate about challenging the status quo of biomedical research and drug development. Her work as a molecular biologist, writer, public speaker, and lifestyle & fitness model, all contribute to the unique lens with which she examines the intersection of science and culture. Dr. Robinton completed her PhD in Human Biology and Translational Medicine at Harvard University in 2016 and landed on the Forbes 30 Under 30 list in 2017 for her scientific discoveries. She is currently building a company focused on ovarian health and longevity with an aim to tackle aging in women while addressing the historic sex and gender disparity in biomedical research and healthcare.
Biomedical research and healthcare are plagued by historic sex and gender disparities. But a new dawn is on the horizon — and we’re running towards it at full speed. Join us to discuss how...
The end of the pandemic is tantalisingly close, but what about the next pandemic? Have we learnt enough to prevent it from happening? We talk with AI health pioneer Eric Topol about his...